MIS Sacroiliac Joint Fusion Market Trends and Forecast
The future of the global MIS sacroiliac joint fusion market looks promising with opportunities in the hospital and ASC markets. The global MIS sacroiliac joint fusion market is expected to grow with a CAGR of 12.7% from 2025 to 2031. The major drivers for this market are the increasing prevalence of spinal disorders, the rising demand for minimally invasive procedures, and the growing adoption of advanced surgical techniques.
• Lucintel forecasts that, within the type category, minimally invasive surgery is expected to witness higher growth over the forecast period.
• Within the application category, ASC is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the MIS Sacroiliac Joint Fusion Market
The MIS sacroiliac joint fusion market is experiencing rapid growth driven by technological advancements, increasing prevalence of lower back pain, and a shift towards minimally invasive procedures. As healthcare providers seek more effective and less invasive treatment options, the market is evolving with innovative devices and techniques. Patients are demanding quicker recovery times and fewer complications, prompting manufacturers and clinicians to adopt new solutions. These developments are transforming the landscape of sacroiliac joint fusion, making procedures safer, more accessible, and more efficient. The following key trends highlight the major shifts shaping this dynamic market.
• Rising Adoption of Minimally Invasive Techniques: The demand for minimally invasive procedures is increasing due to their benefits such as reduced pain, shorter hospital stays, and faster recovery. Surgeons are increasingly opting for MIS approaches over traditional open surgeries, which require larger incisions and longer healing times. This trend is driven by technological innovations in surgical tools and implants, making procedures safer and more precise. As a result, patient outcomes improve, and healthcare costs decrease, encouraging wider adoption across healthcare settings.
• Technological Advancements in Implant Design: Innovations in implant materials and design are significantly impacting the market. Modern implants are now made from biocompatible materials that promote bone growth and integration, enhancing stability and longevity. Customizable and adjustable implants allow for better patient-specific solutions, improving surgical success rates. These advancements reduce complications and revision surgeries, boosting confidence among surgeons and patients alike. The continuous evolution of implant technology is a key driver in expanding the market and improving overall treatment efficacy.
• Increasing Prevalence of Sacroiliac Joint Dysfunction: The rising incidence of lower back pain linked to sacroiliac joint dysfunction is fueling market growth. Factors such as obesity, aging populations, and increased awareness are contributing to higher diagnosis rates. As more patients seek effective treatment options, the demand for sacroiliac joint fusion procedures rises. This trend underscores the importance of developing targeted solutions and expanding access to minimally invasive options, ultimately improving quality of life for affected individuals and driving market expansion.
• Growing Preference for Outpatient Procedures: The shift towards outpatient settings is transforming the market landscape. Minimally invasive techniques enable procedures to be performed in outpatient clinics, reducing hospital stays and associated costs. Patients benefit from quicker recovery and less disruption to daily life. Healthcare providers favor outpatient procedures for their efficiency and cost-effectiveness, which is encouraging manufacturers to develop devices suitable for such environments. This trend is expected to continue, further expanding the reach and adoption of MIS sacroiliac joint fusion.
• Increasing Focus on Personalized and Patient-Centric Care: Customization of treatment plans and implants is gaining prominence. Advances in imaging and surgical planning allow for tailored procedures that address individual patient anatomy and pathology. Patient-centric approaches improve satisfaction, outcomes, and overall experience. This trend is prompting the development of more adaptable devices and comprehensive care protocols, fostering better collaboration between clinicians and patients. As personalized medicine becomes more integrated into practice, the market is poised for sustained growth driven by improved patient outcomes and satisfaction.
In summary, these trends are collectively reshaping the MIS sacroiliac joint fusion market by promoting safer, more effective, and patient-friendly solutions. The focus on minimally invasive techniques, technological innovation, and personalized care is driving market expansion and improving treatment outcomes, ultimately transforming how sacroiliac joint dysfunction is managed worldwide.
Recent Development in the MIS Sacroiliac Joint Fusion Market
The MIS sacroiliac joint fusion market has experienced significant growth driven by technological advancements, increasing prevalence of sacroiliac joint dysfunction, and rising awareness of minimally invasive procedures. As healthcare providers seek effective, less invasive treatment options, the market is evolving rapidly. Recent developments reflect innovations in surgical techniques, device improvements, and expanding clinical applications. These changes are shaping the future landscape of sacroiliac joint fusion, making procedures more accessible and improving patient outcomes. The following key developments highlight the current trajectory and transformative shifts within this market.
• Technological Innovations: Development of advanced surgical devices and implants has enhanced procedure precision and safety. New minimally invasive tools allow for quicker surgeries with reduced complications, boosting surgeon confidence and patient acceptance. These innovations are expanding the scope of sacroiliac joint fusion procedures and improving success rates.
• Growing Clinical Evidence: Increasing research and clinical trials support the efficacy of MIS sacroiliac joint fusion. Evidence demonstrating improved pain relief and functional outcomes is driving adoption among healthcare providers. This growing body of data is influencing clinical guidelines and reimbursement policies, further expanding market reach.
• Rising Patient Awareness: Enhanced awareness campaigns and physician education are informing patients about minimally invasive options. As patients become more informed about the benefits, demand for MIS procedures is rising, encouraging healthcare providers to adopt these techniques and invest in new technologies.
• Expansion of Geographic Markets: Emerging markets in Asia-Pacific and Latin America are witnessing increased adoption of MIS sacroiliac joint fusion. Local healthcare infrastructure improvements and rising healthcare expenditure are facilitating market penetration, creating new growth opportunities for industry players.
• Regulatory Approvals and Reimbursements: Recent approvals of innovative devices by regulatory authorities and favorable reimbursement policies are accelerating market growth. These approvals reduce barriers for hospitals and clinics to adopt new technologies, making MIS sacroiliac joint fusion more accessible and affordable.
In summary, these developments are collectively propelling the MIS sacroiliac joint fusion market forward by enhancing technological capabilities, expanding clinical evidence, increasing patient awareness, broadening geographic reach, and improving regulatory support. As a result, the market is poised for sustained growth, with improved patient outcomes and broader adoption of minimally invasive solutions.
Strategic Growth Opportunities in the MIS Sacroiliac Joint Fusion Market
The MIS sacroiliac joint fusion market is experiencing rapid growth driven by technological advancements, increasing prevalence of lower back pain, and a rising focus on minimally invasive procedures. As healthcare providers seek effective solutions for sacroiliac joint dysfunction, key applications are emerging as significant growth drivers. These opportunities are transforming treatment paradigms, improving patient outcomes, and expanding market reach. Understanding these growth areas is essential for stakeholders aiming to capitalize on the evolving landscape and meet the increasing demand for minimally invasive sacroiliac joint fusion solutions.
• Increasing adoption in orthopedic surgeries: The rising incidence of sacroiliac joint dysfunction and degenerative conditions is prompting more orthopedic surgeons to adopt minimally invasive fusion techniques, leading to higher procedure volumes and market expansion.
• Expansion in pain management clinics: As awareness of minimally invasive options grows, pain management clinics are increasingly offering sacroiliac joint fusion, broadening access and driving demand for specialized devices and procedures.
• Growing use in sports medicine: Athletes and physically active individuals are increasingly seeking minimally invasive solutions for sacroiliac joint issues, boosting the application of fusion procedures in sports medicine and related fields.
• Application in elderly care: The aging population with degenerative joint conditions is fueling demand for minimally invasive sacroiliac fusion procedures, which offer reduced recovery times and improved quality of life for elderly patients.
• Integration with regenerative medicine: Combining sacroiliac joint fusion with regenerative therapies such as platelet-rich plasma (PRP) and stem cell treatments is opening new avenues for comprehensive joint management, enhancing treatment efficacy and market growth.
These growth opportunities are significantly impacting the MIS sacroiliac joint fusion market by expanding its application scope, increasing procedural volumes, and fostering innovation. As demand for minimally invasive, effective solutions continues to rise, the market is poised for sustained growth, driven by technological advancements and evolving clinical practices.
MIS Sacroiliac Joint Fusion Market Driver and Challenges
The MIS sacroiliac joint fusion market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in minimally invasive surgical techniques have revolutionized treatment options, making procedures safer and more efficient. Economic factors such as increasing healthcare expenditure and rising prevalence of sacroiliac joint disorders drive demand for innovative solutions. Regulatory approvals and guidelines also play a crucial role in shaping market dynamics by ensuring safety and efficacy. Additionally, demographic shifts, including aging populations, contribute to the rising need for effective interventions. These multifaceted drivers and challenges collectively impact the markets expansion, innovation, and adoption rates, influencing stakeholders across the healthcare ecosystem.
The factors responsible for driving the MIS sacroiliac joint fusion market include:
• Technological Advancements: The development of minimally invasive surgical techniques has significantly improved patient outcomes by reducing operative time, minimizing scarring, and decreasing recovery periods. Innovations such as advanced imaging guidance and specialized implants have enhanced procedural precision and safety, encouraging wider adoption among surgeons. These technological improvements have expanded the treatment options for sacroiliac joint dysfunction, making the procedure more accessible and appealing to both clinicians and patients, thereby fueling market growth.
• Rising Prevalence of Sacroiliac Joint Disorders: Increasing incidence of sacroiliac joint dysfunction due to factors like aging, obesity, and trauma has heightened demand for effective surgical interventions. As awareness about minimally invasive options grows, more patients seek surgical solutions, contributing to market expansion. The growing burden of chronic lower back pain linked to sacroiliac joint issues further amplifies the need for reliable fusion procedures, driving innovation and investment in this sector.
• Healthcare Expenditure and Reimbursement Policies: Rising healthcare spending globally, coupled with favorable reimbursement policies for minimally invasive procedures, has made sacroiliac joint fusion more accessible. Insurance coverage and government support reduce out-of-pocket costs for patients, encouraging more to opt for surgical treatment. This economic support boosts market demand, stimulates research and development, and accelerates the adoption of advanced fusion devices and techniques.
• Increasing Adoption of Image-Guided Procedures: The integration of advanced imaging technologies such as fluoroscopy, CT, and navigation systems has improved the accuracy and safety of sacroiliac joint fusion surgeries. These image-guided procedures reduce complications and enhance patient outcomes, leading to higher acceptance among surgeons. The technological synergy between imaging and surgical tools is a key driver, expanding the market by enabling more precise and minimally invasive interventions.
• Growing Awareness and Physician Training: Enhanced awareness about sacroiliac joint dysfunction and its treatment options among healthcare professionals and patients has increased demand for surgical solutions. Additionally, specialized training programs and workshops have equipped surgeons with the skills necessary to perform MIS sacroiliac joint fusion confidently. This increased expertise and knowledge dissemination foster market growth by expanding the pool of qualified practitioners and encouraging procedure adoption.
The challenges facing this MIS sacroiliac joint fusion market include:
• Regulatory and Reimbursement Barriers: Despite technological advancements, regulatory hurdles and inconsistent reimbursement policies across regions pose significant challenges. Lengthy approval processes for new devices and procedures can delay market entry, while inadequate reimbursement discourages healthcare providers from adopting new techniques. These barriers hinder rapid market growth and limit access to innovative treatments, especially in emerging markets.
• High Cost of Devices and Procedures: The cost associated with advanced implants, imaging equipment, and minimally invasive surgical setups remains a significant obstacle. High procedural costs can limit patient access, especially in regions with limited healthcare budgets or inadequate insurance coverage. This economic barrier restricts market expansion and necessitates cost-effective innovations to broaden adoption.
• Limited Awareness and Training in Certain Regions: In some developing areas, lack of awareness about sacroiliac joint dysfunction and limited training opportunities for surgeons impede the adoption of MIS fusion techniques. This results in underutilization of available treatments and hampers market growth in these regions. Overcoming educational and infrastructural gaps is essential for expanding the market globally.
In summary, the MIS sacroiliac joint fusion market is driven by technological innovations, increasing disease prevalence, supportive economic policies, and enhanced procedural accuracy. However, regulatory challenges, high costs, and regional disparities in awareness and training pose significant hurdles. The interplay of these factors will shape the markets future trajectory, requiring strategic efforts to overcome barriers and leverage growth opportunities. Overall, the market is poised for continued expansion, provided stakeholders address these challenges effectively.
List of MIS Sacroiliac Joint Fusion Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies MIS sacroiliac joint fusion companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the MIS sacroiliac joint fusion companies profiled in this report include-
• SI-BONE
• Medtronic
• Zimmer Biomet
• Orthofix
• RTI Surgical
• Xtant Medical
• Globus Medical
• Life Spine
• CoreLink
• VGI Medical
MIS Sacroiliac Joint Fusion Market by Segment
The study includes a forecast for the global MIS sacroiliac joint fusion market by type, application, and region.
MIS Sacroiliac Joint Fusion Market by Type [Value from 2019 to 2031]:
• Minimally Invasive Surgery
• Open Surgery of Sacroiliac Joint Fusion
MIS Sacroiliac Joint Fusion Market by Application [Value from 2019 to 2031]:
• Hospitals
• ASC
MIS Sacroiliac Joint Fusion Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the MIS Sacroiliac Joint Fusion Market
The MIS sacroiliac joint fusion market has experienced significant growth driven by technological advancements, increasing prevalence of sacroiliac joint dysfunction, and rising awareness of minimally invasive procedures. Countries are adopting innovative techniques and expanding healthcare infrastructure to meet the rising demand. Regulatory approvals and strategic collaborations are further accelerating market expansion. Each country’s unique healthcare policies and technological adoption rates influence the pace and nature of developments in this market. Understanding these regional trends is crucial for stakeholders aiming to capitalize on emerging opportunities and improve patient outcomes through advanced minimally invasive solutions.
• United States: The US market has seen rapid adoption of MIS sacroiliac joint fusion devices, driven by high healthcare expenditure and technological innovation. Key players are launching new products with improved safety and efficacy profiles, supported by favorable reimbursement policies. Increasing awareness among healthcare providers and patients about minimally invasive options is boosting demand. Additionally, strategic collaborations and acquisitions are strengthening market presence. The FDA’s approval of advanced fusion devices has further propelled market growth, with a focus on outpatient procedures and enhanced patient recovery times.
• China: China’s market is expanding due to rising cases of sacroiliac joint dysfunction and a growing healthcare infrastructure. Local manufacturers are developing cost-effective MIS fusion devices to cater to a large patient base. Government initiatives to improve healthcare access and technological adoption are facilitating market growth. Increasing awareness among surgeons about minimally invasive techniques and rising healthcare expenditure are also contributing factors. Importantly, collaborations with international companies are helping to introduce advanced devices and expand distribution networks across the country.
• Germany: Germany’s market is characterized by high healthcare standards and a strong focus on innovative medical technologies. The adoption of MIS sacroiliac joint fusion procedures is increasing, supported by well-established healthcare infrastructure and reimbursement systems. German companies are investing in research and development to improve device design and procedural outcomes. The country’s emphasis on minimally invasive surgeries aligns with global trends, leading to a rise in outpatient procedures. Regulatory frameworks are streamlined, enabling faster approval of new devices, which further accelerates market growth.
• India: The Indian market is witnessing rapid growth due to increasing awareness of minimally invasive procedures and a rising burden of musculoskeletal disorders. Local manufacturers are offering affordable MIS fusion devices to meet the demand for cost-effective healthcare solutions. Government initiatives aimed at improving healthcare access and infrastructure are facilitating market expansion. The growing number of trained surgeons and rising healthcare expenditure are also contributing to increased adoption of MIS techniques. Strategic partnerships with global companies are helping to introduce advanced devices and expand the reach of minimally invasive procedures across urban and rural areas.
• Japan: Japan’s market is driven by technological innovation and a high prevalence of degenerative joint conditions. The country’s aging population is increasing demand for minimally invasive solutions like MIS sacroiliac joint fusion. Japanese companies are focusing on developing advanced, minimally invasive devices with improved precision and safety features. The healthcare system’s emphasis on outpatient procedures and quick recovery aligns with global trends. Regulatory processes are efficient, enabling timely approval of new devices. Additionally, collaborations with international firms are fostering innovation and expanding the availability of cutting-edge fusion technologies in Japan.
Features of the Global MIS Sacroiliac Joint Fusion Market
Market Size Estimates: MIS sacroiliac joint fusion market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: MIS sacroiliac joint fusion market size by type, application, and region in terms of value ($B).
Regional Analysis: MIS sacroiliac joint fusion market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the MIS sacroiliac joint fusion market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the MIS sacroiliac joint fusion market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for MIS sacroiliac joint fusion market?
Answer: The global MIS sacroiliac joint fusion market is expected to grow with a CAGR of 12.7% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the MIS sacroiliac joint fusion market?
Answer: The major drivers for this market are the increasing prevalence of spinal disorders, the rising demand for minimally invasive procedures, and the growing adoption of advanced surgical techniques.
Q3. What are the major segments for MIS sacroiliac joint fusion market?
Answer: The future of the MIS sacroiliac joint fusion market looks promising with opportunities in the hospital and ASC markets.
Q4. Who are the key MIS sacroiliac joint fusion market companies?
Answer: Some of the key MIS sacroiliac joint fusion companies are as follows:
• SI-BONE
• Medtronic
• Zimmer Biomet
• Orthofix
• RTI Surgical
• Xtant Medical
• Globus Medical
• Life Spine
• CoreLink
• VGI Medical
Q5. Which MIS sacroiliac joint fusion market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, minimally invasive surgery is expected to witness higher growth over the forecast period.
Q6. In MIS sacroiliac joint fusion market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the MIS sacroiliac joint fusion market by type (minimally invasive surgery and open surgery of sacroiliac joint fusion), application (hospitals and ASC), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to MIS Sacroiliac Joint Fusion Market, MIS Sacroiliac Joint Fusion Market Size, MIS Sacroiliac Joint Fusion Market Growth, MIS Sacroiliac Joint Fusion Market Analysis, MIS Sacroiliac Joint Fusion Market Report, MIS Sacroiliac Joint Fusion Market Share, MIS Sacroiliac Joint Fusion Market Trends, MIS Sacroiliac Joint Fusion Market Forecast, MIS Sacroiliac Joint Fusion Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.